PLX

SetupConviction 72LongHealthcareScan · Fri, Oct 9, 2026

Flat basebase

Protalix BioTherapeutics, Inc. (PLX) closed at $2.78 (+2.96%) on Oct 9, 2026. It is in the "Setting up" lane with a flat base pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 81, -11.8% from its 52-week high, +59.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

PLX$2.78+2.96%

ResistanceSupportVol 14

Vol MA14 826.59K

Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9

Trade plan

LongReward : Risk1.71

Entry

2.85

Risk

Stop

2.70

-5.1% to stop

Reward

Target 1

3.10

+8.8% to target

Stretch

Target 2

3.35

+17.5% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Protalix BioTherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.protalix.com ↗

Price2.78

Change+2.96%

Gap+1.48%

Rel volume0.79×

Avg volume821.96K

Avg $ vol2.24M

SMA 202.73

SMA 502.58

SMA 2002.36

Price vs 50+7.80%

Price vs 200+17.89%

MA stackbullish

50/200 cross—

Supertrendup · 2.53

RSI (14)59

MACD hist-0.01

MACD cross—

Stoch %K / %D72 / 52

ADX (14)28

+DI / −DI23 / 17

RSI divergence—

MACD divergence—

ATR %3.50%

ADR %3.48%

52w high3.15

52w low1.67

From 52w high-11.75%

Above 52w low+66.47%

New 52w highNo

SqueezeOn · 8d

Bollinger width6.59%

%B0.80

Donchian pos72.14%

Donchian high2.85

Donchian low2.60

AVWAP (52w high)2.40

vs AVWAP high+15.83%

AVWAP (52w low)2.35

vs AVWAP low+18.50%

OBV trendFlat

Chaikin MF (20)0.23

Today vs 20d0.79×

Avg vol (14d)826.59K

Avg vol (20d)821.96K

Avg $ vol (20d)2.24M

Market cap223.99M

RS Rating81 / 99

RS 3m (vs SPY)+12.40%

RS 6m (vs SPY)+6.29%

RS line new highNo

Trend template6/8

Technical rank89.7

1 week+2.58%

1 month+1.83%

3 months+16.32%

6 months+20.87%

1 year+8.17%

YTD+59.77%

P/E-33.92

P/B3.14

P/S4.25

P/FCF-16.43

EPS-0.0800

Div yield—

ROE-9.25%

ROA-5.99%

Debt/Eq0.01

Current2.94

EV/EBITDA—

Gross margin7.60%

Net margin-12.52%

Rev growth-1.23%

EPS growth-325.24%

Price target12.00

Target upside331.65%

Analyst ratingBuy

Institutional18.57%

Ent. value197.48M

Revenue19.9M

Net income3.78M

Gross profit-1.25M

Free cash flow-13.63M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out80.57M

Employees226

ListedTue, Jan 2, 1996

Free float71.57M

Float %89.0%

Short interest3.17M

Days to cover4.8d

Short volume22.8%

Squeeze score33 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.05 vs −$0.01

Last surprise+600.0% beat

Setup gradeB

Conviction72 / 100

Pattern quality71%

Tech rank89.7 / 100

Group rank14 / 100

Status laneSetting up

Setup directionLong

Pattern familyBase

Resistance2.85

Support2.60

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PLX

All disclosures →

No recent disclosed trades by Congress in PLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PLX

Insider	Side	Shares	Value	Traded	Filed
Schwartz Aharon Director · Stock Options (Right to Buy) · 2026-09-03	Grant	17K	—	2026-09-03	2026-09-09
Schwartz Aharon Director · Restricted Stock Units · 2026-09-03	Grant	8.5K	—	2026-09-03	2026-09-09

SEC filings

EDGAR filings in PLX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

PLX

Trade plan

Recent news

Get daily signals & real-time alerts.